Catheter based local delivery of fluid paclitaxel: The Tübingen experience

EuroIntervention

Volumn 7, Issue SUPPL. K, 2011, Pages

  Herdeg, Christian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL;

BALLOON CATHETER; BALLOON DILATATION; BARE METAL STENT; CAROTID ARTERY INJURY; CONCENTRATION RESPONSE; CORONARY ARTERY OBSTRUCTION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG POTENCY; DRUG SAFETY; DRUG SPECIFICITY; EDITORIAL; EQUIPMENT DESIGN; HUMAN; IN-STENT RESTENOSIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; CARDIOVASCULAR AGENTS; CATHETERS; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; GERMANY; HUMANS; MIDDLE AGED; PACLITAXEL; PROSTHESIS DESIGN; STENTS; TREATMENT OUTCOME;

EID: 80355128288     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7SKA3     Document Type: Editorial

References (26)

1. Baumbach A, Oberhoff M, Bohnet A, Miljak T, Herdeg C, Horch B, Blessing E, Kunert W, Haase KK, Karsch KR. Efficacy of low molecular weight heparin delivery with the Dispatch catheter following balloon angioplasty in the rabbit iliac artery. Cathet Cardiovasc Diagn 1997;41:303-307. (Pubitemid 27283814)
2. Herdeg C, Oberhoff M, Baumbach A, Haase KK, Horch B, Kranzhöfer A, Karsch KR. Local drug delivery with porous balloons in the rabbit: Assessment of vascular injury for an improvement of application parameters. Cathet Cardiovasc Diagn 1997;41:308-314. (Pubitemid 27283815)
3. Baumbach A, Oberhoff M, Rübsamen K, Jochims K, Herdeg C, Kranzhöfer A, Safer A, Karsch KR. Porous balloon delivery of low molecular weight heparin in the dog coronary artery. A safety study. Eur Heart J 1996;17:1538-1545. (Pubitemid 26345143)
4. Oberhoff M, Herdeg C, Baumbach A, Shamet K, Kranzhöfer A, Weingärtner O, Rübsamen K, Kluge M, Karsch KR. Time course of smooth muscle cell proliferation after local drug delivery of low molecular weight heparin using a porous balloon catheter. Cathet Cardiovasc Diagn 1997;41:268-274. (Pubitemid 27283810)
5. Axel DI, Kunert W, Göggelmann C, Oberhoff M, Herdeg C, Küttner A, Wild DH, Brehm B.R, Riessen R, Köveker G, Karsch KR. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-645. (Pubitemid 27329445)
6. Oberhoff M, Baumbach A, Hermann T, Diehl C, Maier R, Athanasiadis A, Herdeg C, Bohnet A, Haase KK, Voelker W, Baildon R, Veldhof S, Karsch KR. Local and systemic delivery of low molecular weight heparin following PTCA and 6-month follow- up of the initial clinical experience with the porous balloon (PILOT-study). Cathet Cardiovasc Diagn 1998;44:267-274.
7. Oberhoff M, Novak S, Herdeg C, Baumbach A, Kranzhöfer A, Bohnet A, Horch B, Hanke H, Haase KK, Karsch KR. Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty. Cardiovasc Res 1998;38:751-762. (Pubitemid 28319885)
8. Herdeg C, Oberhoff M, Karsch KR. Antiproliferative stent coatings: Taxol and related compounds. Semin Intervent Cardiol 1998;3:197-199.
9. Baumbach A, Herdeg C, Kluge M, Oberhoff M, Lerch M, Haase KK, Wolter W, Schröder S, Karsch, KR. Local drug delivery: Impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall. Cathet Cardiovasc Intervent 1999;47:102-106.
10. Herdeg C, Oberhoff M, Baumbach A, Blattner A, Küttner A, Schröder S, Haase KK, Karsch KR. Visualization and comparison of drug effects after local paclitaxel delivery with different catheter types. Basic Res Cardiol 1999;94:454-463. (Pubitemid 30018956)
11. Baumbach A, Oberhoff M, Herdeg C, Lerch M, Schröder S, Meisner C, Rübsamen K, Karsch KR. Local delivery of a low molecular weight heparin following stent implantation in the pig coronary artery. Basic Res Cardiol 2000;95:173-178. (Pubitemid 30325892)
12. Herdeg, C, Oberhoff, M, Baumbach, A, Blattner, A, Axel, D.I, Schröder, S, Heinle, H, Karsch, KR. Local paclitaxel delivery for the prevention of restenosis: Biological effects and efficacy in vivo. J Am Coll Cardiol 2000;35:1969-1976. (Pubitemid 30342882)
13. Herdeg C, Oberhoff M, Siegel-Axel D.I, Baumbach A, Blattner A, Küttner A, Schröder S, Karsch KR. Paclitaxel: Ein Chemotherapeutikum zur Restenoseprophylaxe? Experimentelle Untersuchungen in vitro und in vivo. Z. Kardiol 2000;89:390-397. (Pubitemid 30407524)
14. Herdeg C, Oberhoff M, Baumbach A, Schröder S, Karsch KR. Lokale Applikation von niedermolekularem Heparin zur Restenoseprophylaxe: Experimentelle und klinische Ergebnisse verschiedener Systeme. Perfusion 2000;13:256-261.
15. Oberhoff M, Kunert W, Herdeg C, Küttner A, Kranzhöfer A, Horch B, Baumbach A, Karsch KR. Inhibition of smooth muscle cell proliferation after local drug delivery of the antimitotic drug paclitaxel using a porous balloon catheter. Basic Res Cardiol 2001;96:275-282. (Pubitemid 32433062)
16. Oberhoff M, Herdeg C, Al-Ghobainy R, Cetin S, Küttner A, Horch B, Baumbach A, Karsch KR. Local delivery of paclitaxel using the double-balloon perfusion catheter before stenting in the porcine coronary artery. Catheter Cardiovasc Interv. 2001;53:562-568. (Pubitemid 32729262)
17. Oberhoff M, Herdeg C, Baumbach A, Karsch KR. Stent-based antirestenotic coatings (Sirolimus/Paclitaxel). Catheter Cardiovasc Interv. 2002;55:404-408. (Pubitemid 34204888)
18. Herdeg C, Blattner A, Oberhoff M, Baumbach A, Schröder S, Karsch KR. Auswirkungen von Paclitaxel auf neointimale Proliferation und Remodeling in der A. carotis des Kaninchens: Darstellung der Ergebnisse an einem Modellgefäß. Perfusion 2002;15:230-238.
19. Herdeg C, Oberhoff M, Baumbach A, Schröder S, Leitritz M, Blattner A, Siegel-Axel D.I, Meisner C, Karsch KR. Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery. Cardiovasc Res 2003;57:544-553. (Pubitemid 36144231)
20. Bültmann A, Herdeg C, Li Z, Munch G, Baumgartner C, Langer H, Kremmer E, Geisler T, May A, Ungerer M, Gawaz M. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo. Thromb Haemost. 2006;95:763-766.
21. Herdeg C, Göhring-Frischholz K, Popowski Y, Geisler T, May A, Haase KK, Gawaz M. Genie™ catheter for liquid local drug delivery. EuroIntervention 2007;3:286-288.
22. Dommke C, Haase KK, Sueselbeck T, Streitner I, Haghi D, Metz J, Borggrefe M, Herdeg C. Local paclitaxel delivery after coronary stenting in an experimental animal model. Thromb Haemost 2007;98:674-680. (Pubitemid 47412896)
23. Herdeg C, Göhring-Frischholz K,Geisler T, Haase KK, Gawaz M. Successful local antiproliferative paclitaxel delivery in a repeatedly restenosed lesion of the right coronary artery after drug eluting-stent implantation. Clin Res Cardiol. 2008;97:49-52.
24. Herdeg C, Geisler T, Gawaz M. Catheter-based local antiproliferative therapy in kissing balloon technique for in-stent stenosis of coronary artery bifurcation lesions. Can J Cardiol. 2008;24:309-311. (Pubitemid 351771467)
25. Herdeg C, Göhring-Frischholz K, Zuern C, Geisler T, Hartmann E, Hoevelborn T, Haase KK, Gawaz M. Local catheter- based delivery of antithrombotic or antiproliferative drugs: a new concept for prevention of restenosis. Thromb Res 2008;123:236-243.
26. Herdeg C; Gohring-Frischholz K, Haase KK, Geisler T, Zuern C, Hartmann U, Woehrle J, Nusser T, Dippon J, May A, Gawaz M. Catheter-Based Delivery of Fluid Paclitaxel for Prevention of Restenosis in Native Coronary Artery Lesions After Stent Implantation. Circulation Cardiovasc. Intervent. 2009;2:294-301.